Cellworks differentiated design approach and methodology leverages best practices from orthogonal domains like semiconductor engineering. The novel and predictive technology enables the virtualization of experiments through emulation of in vitro and in vivo systems under different environment conditions. Quantitative assay readouts allow design of therapies with novel mechanism of action...

Read More

Cellworks intends to be a fully integrated provider of novel high efficacy and low toxicity personalized pharmaceutical solutions directly to consumers or through alliance with strategic partners. Our business differentiation is an ultra short design time with the lowest development cost and high predictability of success once entering clinical trials.


Read More

EU FP7 MM4TB Grant Award – Cellworks

Bangalore BIO 2011 –
Bio Excellence Award to Cellworks

Cellworks Presenting at Gordon Conference 2011 –
Barrier Function of Mammalian Skin